Oramed Pharmaceuticals (ORMP) Investor Presentation - Slideshow

Addressing the Multibillion-Dollar Injectable Drug Markets with Oral Formulations January 2022 Safe Harbor Certain statements contained in this material are forward-looking statements. These forward-looking statements are based on the current expectations of the management of Oramed only, including with respect to clinical trials, milestones and the potential benefits of Oramed's products, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from thos ...